Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: February 9, 2007
Last updated: December 18, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)